PBS Biotech Industrializes Cell Therapy Development with Rockwell Automation

Markets PR Newswire By PR Newswire 29 Sep 2026 15:00 1 min read
PBS Biotech Industrializes Cell Therapy Development with Rockwell Automation

Leading bioreactor manufacturer accelerates time-to-results and simplifies global deployment with standardized automation MILWAUKEE, Sept. 29, 2026 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital...

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Analyst targets on Rockwell Automation

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $ROK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Rockwell Automation →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.